New Drug ION224 Stops Fatty Liver Disease at the Source Without Weight Loss
A UC San Diego trial shows ION224 blocks liver fat production, cutting inflammation and scarring in 60% of MASH patients.
20 articles
A UC San Diego trial shows ION224 blocks liver fat production, cutting inflammation and scarring in 60% of MASH patients.
Japanese scientists engineered hybrid vitamin K molecules that are 3x more potent at regrowing neurons, potentially transforming Alzheimer's treatment.
Scientists found dragonflies see deep red light like humans do, opening doors for new light-based therapies that work inside the body.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.
MIT researchers discover cysteine activates immune cells that boost intestinal stem cells, opening doors to nutrition-based gut therapies.
New research reveals how hormone FGF21 activates brain circuits to boost metabolism and reverse obesity, offering alternative to GLP-1 drugs.
A 3-week placebo trial improved memory, physical performance, and stress in healthy older adults — even when participants knew the pills were fake.
Scientists mapped a two-pathway gut-brain alarm that shifts appetite from sugar to protein when essential amino acids drop.
A novel β2 agonist pill boosts fat burning via skeletal muscle, preserving muscle mass while improving blood sugar in early trials.
Scientists found astrocytes, not just neurons, control when you feel full after eating through a newly discovered glucose-sensing pathway.
A University of Exeter trial found twice-daily beetroot juice lowered blood pressure in adults 60+ by shifting oral microbiome composition.
A new study finds intermittent fasting triggers coordinated changes in gut microbiome and brain regions controlling appetite and cravings.
A 600,000-person study finds semaglutide and other GLP-1 drugs reduce substance use disorders by up to 25% and lower overdose deaths.
New evidence suggests 500mg daily vitamin C cuts anxiety within two weeks, but whole fruits may offer safer, broader benefits.
FGF21 extends lifespan in animals by 30-40%. Here's what exercise and diet research reveals about boosting it naturally.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
A newly identified trigger in brown fat activates a hidden calorie-burning pathway and may unlock new treatments for bone disease.
A clinical trial found testosterone gel plus exercise prevented visceral fat increases in women over 65 recovering from hip fractures.
Cutting off biotin halts cancer cell growth by disabling a key enzyme, revealing a promising new therapeutic target.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.